Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03255070
Title A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Ambrx, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
USC Norris Cancer Hospital Los Angeles California 90033 United States Details
UCLA Hematology-Oncology Santa Monica California 90095 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
Baylor Sammons Cancer Center Dallas Texas 75246 United States Details
Research Site East Albury New South Wales 2640 Australia Details
Research Site North Sydney New South Wales 2640 Australia Details
Mater Misericordiae Limited South Brisbane Queensland 4101 Australia Details
Princess Alexandria Hospital Woolloongabba Queensland 4102 Australia Details
Monash Health Clayton Victoria 3168 Australia Details
Research Site Frankston Victoria 3199 Australia Details
Research Site Nedlands Western Australia 6009 Australia Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field